Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status

BACKGROUND: Phase III, open-label, single-center, controlled study in South Africa (ClinicalTrials.gov: NCT00829010) to evaluate immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in human immunodeficienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Madhi, Shabir A., Koen, Anthonet, Jose, Lisa, van Niekerk, Nadia, Adrian, Peter V., Cutland, Clare, François, Nancy, Ruiz-Guiñazú, Javier, Yarzabal, Juan-Pablo, Moreira, Marta, Borys, Dorota, Schuerman, Lode
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266190/
https://www.ncbi.nlm.nih.gov/pubmed/28079828
http://dx.doi.org/10.1097/MD.0000000000005881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266190/
https://www.ncbi.nlm.nih.gov/pubmed/28079828
http://dx.doi.org/10.1097/MD.0000000000005881

Ejemplares similares